Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Nayef A. Alzahrani"'
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 1106-1114 (2022)
Background and objectives The management of patients with extensive appendiceal mucinous neoplasms and mesothelioma is controversial. Our aims were to analyze overall survival (OS), disease-free survival (DFS) and independent prognostic factors assoc
Externí odkaz:
https://doaj.org/article/7078bf554ac740fcbf5e1d3fe0ceb2f2
Autor:
Peter H. Cashin, Jesus Esquivel, Stein G. Larsen, Winston Liauw, Nayef A. Alzahrani, David L. Morris, Vahan Kepenekian, Isabelle Sourrouille, Frédéric Dumont, Jean-Jacques Tuech, Cécilia Ceribelli, Beranger Doussot, Olivia Sgarbura, Francois Quenet, Olivier Glehen, Oliver M. Fisher
Publikováno v:
EClinicalMedicine, Vol 55, Iss , Pp 101746- (2023)
Summary: Background: There is a paucity of studies evaluating perioperative systemic chemotherapy in conjunction with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colorectal cancer peritoneal meta
Externí odkaz:
https://doaj.org/article/8ae6495d57604af5ac3b1364de789a39
Publikováno v:
Journal of Surgical Case Reports. 2022
Liposarcomas are a group of malignancies that mainly affect adults. Myxoid pleomorphic liposarcoma (MPL) is a newly added subtype of liposarcomas [1]. It is extremely rare and mostly affects infants and children, and it has a predilection for the med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92d5b1e1d8b2489796cd48d4bfa0c505
https://doi.org/10.1093/jscr/rjac531
https://doi.org/10.1093/jscr/rjac531
Autor:
Anais Alonso, David L. Morris, Nayef A. Alzahrani, Shoma Barat, Meredith Potter, Helen Kennedy
Publikováno v:
Pleura and Peritoneum, Vol 6, Iss 4, Pp 155-160 (2021)
Pleura and Peritoneum
Pleura and Peritoneum
Objectives There are currently scarce data exploring ureteric reimplantation (UR) during cytoreductive surgery (CRS). Methods We identified patients undergoing CRS for peritoneal surface malignancies (PSM) of any origin at a single high-volume unit.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1060d37a2922f7749ca090c7489c330c
https://doi.org/10.1515/pp-2021-0130
https://doi.org/10.1515/pp-2021-0130
Publikováno v:
Anticancer Research. 41:5569-5575
Background/aim While controversial, cytoreductive surgery (CRS) with heated intra-peritoneal chemotherapy (HIPEC) and early postoperative intra-peritoneal chemotherapy (EPIC) remains the mainstay of treatment for low grade appendiceal neoplasm with p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa7c06542d1c743e4caa2e0423f65f79
https://doi.org/10.21873/anticanres.15370
https://doi.org/10.21873/anticanres.15370
Autor:
Joshua Lansom, Amit Sarkar, Anindita Dey, Nayef A. Alzahrani, Oliver M. Fisher, David L. Morris
Publikováno v:
European Journal of Surgical Oncology. 47:1406-1410
Background Higher Peritoneal Cancer Index (PCI) requires more extensive surgery and maybe associated with more limited outcomes. The aim of this study in a high-volume centre in Australia was to analyse the outcomes in PCI 39 patients regarding short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b584cd2340569563cbb6a719760f29a
https://doi.org/10.1016/j.ejso.2020.11.138
https://doi.org/10.1016/j.ejso.2020.11.138
Publikováno v:
Anticancer Research. 41:1641-1646
Background/aim Cisplatin increases the risk of acute kidney injury (AKI) during systemic chemotherapy. However, little is known about its risk of inducing AKI when used during intraperitoneal chemotherapy. This study aimed to determine the incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c16f8220284566f0be88f784ead4beb4
https://doi.org/10.21873/anticanres.14926
https://doi.org/10.21873/anticanres.14926
Autor:
JAMES R.M. COLBOURNE, SAM T. ALHAYO, BEESHMAN NANDAKUMAR, SHOMA BARAT, WINSTON LIAUWI, DAVID L. MORRIS, NAYEF A. ALZAHRANI
Publikováno v:
In Vivo
Background: Iterative cytoreduction (iCRS) and hyperthermic intraperitoneal chemotherapy is a treatment for recurrence of peritoneal carcinomatosis. There are considerable upfront costs for this approach for which the cost-effectiveness has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0906284ce87836850bcc97bd3cffd537
https://europepmc.org/articles/PMC9087096/
https://europepmc.org/articles/PMC9087096/
Publikováno v:
ANZ Journal of Surgery. 92:608-610
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3eab8ab162c533a2aa149d8f75fc805
https://doi.org/10.1111/ans.17105
https://doi.org/10.1111/ans.17105
Publikováno v:
ANZ Journal of Surgery. 90:1953-1957
Background Cytoreductive surgery (CRS) for the management of peritoneal carcinomatosis (PC) can involve significant blood loss which necessitates the transfusion of blood products. This poses a particular challenge in the Jehovah's Witnesses populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdc5e6a4dcf12d6442a25bc3bb6c572e
https://doi.org/10.1111/ans.16101
https://doi.org/10.1111/ans.16101